Calidi Biotherapeutics, Inc. Annual Current Income Tax Expense (Benefit) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Calidi Biotherapeutics, Inc. annual Current Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
  • Calidi Biotherapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $16K, a 45.5% increase from 2022.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16K +$5K +45.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 $11K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.